Zürich BioGenix
Ipamorelin · 10mg
Ipamorelin · 10mg
Couldn't load pickup availability
✓ HPLC Purity >99% ✓ COA on Every Batch ✓ Cold Chain Maintained ✓ EU Compliant
Ipamorelin is a selective, third-generation growth hormone secretagogue (GHS) and ghrelin mimetic that acts on the GHS-R1a receptor to stimulate pulsatile growth hormone release from the anterior pituitary. Compared to other GHRPs, it demonstrates high GH selectivity with minimal effect on cortisol, prolactin, or ACTH. Research applications include growth hormone axis modulation, body composition studies, recovery biology, and the investigation of GH-IGF-1 signalling pathways.
Synthesised and lyophilised in Zürich to >99% HPLC purity. Lot-traceable with full COA availab Ipamorelin was developed as a highly selective growth hormone secretagogue. Key studies by Raun et al. (1998) in European Journal of Endocrinology demonstrated its potent and selective GH-releasing activity with no effect on cortisol, prolactin, or ACTH, distinguishing it from earlier GHSs. Research applications include body composition studies, recovery biology, sleep quality enhancement, and GH-IGF-1 axis investigations. Its selectivity profile makes it a preferred research tool for isolating GH-specific effects.Technical Specifications
Chemical Name
Ipamorelin
CAS Number
170851-70-4
Molecular Formula
C38H49N9O5
Molecular Weight
711.87 g/mol
Sequence
Aib-His-D-2-Nal-D-Phe-Lys-NH2 (pentapeptide)
Receptor Target
GHS-R1a (ghrelin receptor)
Purity
>99% (HPLC-UV)
Form
Lyophilised Powder
Storage
-20C, protect from light and moisture
Reconstitution
Bacteriostatic water or sterile saline
Research & Literature
For research purposes only. Not for human consumption. Supplied in accordance with EU Regulation (EC) No 1907/2006 (REACH) for research and analytical use.
Share
